Helio Health
Joyce Cheung is a seasoned professional in strategy and operations, currently serving as VP of Strategy and Operations and Head of Commercialization at Helio Genomics since September 2021. Prior to this role, Joyce spent over eight years at ZS Associates, progressing from a Business Associate Intern to a Strategy Insights and Planning Manager, where responsibilities included supporting pipeline and launch strategy, data analytics, and client engagement within Medical Affairs. Joyce's earlier experiences include positions at The Walt Disney Company and Merrill Lynch, complemented by a strong educational background featuring an MBA from the University of California, Berkeley, and bachelor’s degrees from UCLA and The University of Hong Kong.
This person is not in any teams
This person is not in any offices
Helio Health
Helio Health is an AI-driven healthcare company focused on commercializing early cancer detection tests from a simple blood draw. The company’s mission is to simplify cancer screening so lives can be saved by detecting cancer earlier. With Helio’s AI-driven technology, both physicians and their patients gain powerful insights from accurate,accessible, and convenient blood tests. Helio’s development program is focused on liver, colon, breast and lung cancer. Helio Health is headquartered in Irvine, CA, with R&D, GMP and CLIA facilities in Irvine, CA and West Lafayette, IN.